EFFECTS OF 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) ON CELL-PROLIFERATION

被引：0
|
作者：
ELORRIAGA, R [1 ]
FRAGA, PM [1 ]
NAVES, ML [1 ]
CANNATA, JB [1 ]
机构：
[1] HOSP CENT ASTURIAS,BONE & MINERAL RES UNIT,OVIEDO,SPAIN
来源：
KIDNEY INTERNATIONAL | 1994年 / 46卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：587 / 587
页数：1
相关论文
共 50 条
  • [21] EFFICACY AND POSSIBLE ADVERSE-EFFECTS OF THE ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L(1)) IN THALASSEMIA MAJOR
    ALREFAIE, FN
    WONKE, B
    HOFFBRAND, AV
    WICKENS, DG
    NORTEY, P
    KONTOGHIORGHES, GJ
    BLOOD, 1992, 80 (03) : 593 - 599
  • [22] EFFECTIVE CHELATION OF IRON IN BETA-THALASSEMIA WITH THE ORAL CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE
    KONTOGHIORGHES, GJ
    ALDOURI, MA
    HOFFBRAND, AV
    BARR, J
    WONKE, B
    KOUROUCLARIS, T
    SHEPPARD, L
    BRITISH MEDICAL JOURNAL, 1987, 295 (6612): : 1509 - 1512
  • [23] Aluminum removal efficacy of 1,2-dimethyl-3-hydroxypyrid-4-one after subchronic intoxication in rabbits
    Xi, C
    Ping, L
    Shue, W
    CHINESE MEDICAL JOURNAL, 1997, 110 (10) : 745 - 745
  • [24] Influence of the chelator 1,2-dimethyl-3-hydroxypyrid-4-one on aluminum elimination in aluminum-loaded rabbits
    Xi, C
    Ping, L
    Wushide
    Shue, W
    Benjie, W
    TRACE ELEMENTS AND ELECTROLYTES, 1997, 14 (03): : 130 - 133
  • [25] DETAILED INVESTIGATION OF IMMUNE FUNCTION IN PATIENTS (PTS) RECEIVING THE IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) - NO EVIDENCE OF ABNORMALITY AFTER 3 YEARS OF THERAPY
    BERKOVITCH, M
    MEYDAN, N
    DONSKY, J
    COLLINS, AF
    SHER, GD
    MATSUI, D
    KOREN, G
    HACKMAN, R
    ROIFMAN, C
    OLIVIERI, NF
    BLOOD, 1993, 82 (10) : A360 - A360
  • [26] DETAILED INVESTIGATION OF IMMUNE FUNCTION IN PATIENTS (PTS) RECEIVING THE IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) - NO EVIDENCE OF ABNORMALITY AFTER 3 YEARS OF THERAPY
    BERKOVITCH, M
    MEYDAN, N
    DONSKY, J
    COLLINS, AF
    SHER, GD
    MATSUI, D
    KOREN, G
    HACKMAN, R
    ROIFMAN, C
    OLIVIERI, NF
    PEDIATRIC RESEARCH, 1994, 35 (04) : A158 - A158
  • [27] STUDIES OF ALUMINUM MOBILIZATION IN RECTAL DIALYSIS PATIENTS USING THE ORAL CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE
    KONTOGHIORGHES, GJ
    BARR, J
    BAILLOD, RA
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1994, 44-1 (04): : 522 - 526
  • [28] EFFECTIVE IRON CHELATION USING THE ORAL IRON CHELATOR, 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1), IN HOMOZYGOUS BETA-THALASSEMIA MAJOR (HBT) PATIENTS (PTS)
    MATSUI, D
    OLIVIERI, N
    BERKOVITCH, M
    TEMPLETON, D
    WANLESS, I
    BLENDIS, L
    LIU, P
    KOREN, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 145 - 145
  • [29] AGRANULOCYTOSIS IN A PATIENT WITH THALASSEMIA MAJOR DURING TREATMENT WITH THE ORAL IRON CHELATOR, 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE
    ALREFAIE, FN
    VEYS, PA
    WILKES, S
    WONKE, B
    HOFFBRAND, AV
    ACTA HAEMATOLOGICA, 1993, 89 (02) : 86 - 90
  • [30] REDUCTION IN HEPATIC IRON STORES WITH THE ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) IN PATIENTS (PTS) WITH TRANSFUSION DEPENDENT THALASSEMIA (HBT) AND SICKLE-CELL DISEASE (SCD)
    MATSUI, D
    BERKOVITCH, M
    OLIVIERI, N
    KOREN, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 175 - 175
12345